The core activity of Enable Biotech is the development and manufacturing of cell and gene therapies (ATMPs) as well as exosome therapies for clinical trials. The company offers Contract Development and Manufacturing Organization (CDMO) services, including process development, clinical manufacturing, quality control, and regulatory support. Enable Biotech focuses on the needs of start-ups and small companies in the field of advanced therapies, providing flexible and cost-effective solutions for the production of cell and gene therapies.